chr5-141527616-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005219.5(DIAPH1):āc.3230C>Gā(p.Pro1077Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,610,580 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. P1077P) has been classified as Likely benign.
Frequency
Consequence
NM_005219.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DIAPH1 | NM_005219.5 | c.3230C>G | p.Pro1077Arg | missense_variant | 24/28 | ENST00000389054.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DIAPH1 | ENST00000389054.8 | c.3230C>G | p.Pro1077Arg | missense_variant | 24/28 | 5 | NM_005219.5 | A2 | |
DIAPH1 | ENST00000518047.5 | c.3203C>G | p.Pro1068Arg | missense_variant | 23/27 | 5 | P4 | ||
DIAPH1 | ENST00000647433.1 | c.3230C>G | p.Pro1077Arg | missense_variant | 24/29 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000113 AC: 17AN: 150344Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249208Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135196
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460236Hom.: 0 Cov.: 33 AF XY: 0.00000964 AC XY: 7AN XY: 726424
GnomAD4 genome AF: 0.000113 AC: 17AN: 150344Hom.: 0 Cov.: 30 AF XY: 0.0000819 AC XY: 6AN XY: 73216
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 19, 2013 | The Pro1077Arg variant in DIAPH1 has been identified in 0.027% (1/3664) of Afric an American chromosomes from a broad population by the NHLBI Exome Sequencing Pr oject (http://evs.gs.washington.edu/EVS; dbSNP rs376593325). Computational analy ses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In summary, additional data is needed to determine the clinical significance of thi s variant. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 14, 2016 | - - |
Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2023 | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1077 of the DIAPH1 protein (p.Pro1077Arg). This variant is present in population databases (rs376593325, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with DIAPH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 163067). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at